Loading clinical trials...
Loading clinical trials...
Hydroxyurea Optimization Through Precision Study (HOPS): A Prospective, Multi-center, Randomized Trial of Personalized, Pharmacokinetics-guided Dosing of Hydroxyurea Versus Standard Weight-based Dosing for Children With Sickle Cell Anemia.
Conditions
Interventions
Hydroxyurea
Locations
13
United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Children's Hospital of Illinois
Peoria, Illinois, United States
Carle Foundation Hospital
Urbana, Illinois, United States
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana, United States
Indiana Hemophilia & Thrombosis Center, Inc. (IHTC)
Indianapolis, Indiana, United States
Start Date
January 17, 2019
Primary Completion Date
March 19, 2025
Completion Date
March 19, 2025
Last Updated
June 18, 2025
NCT06820515
NCT07392216
NCT05359991
NCT05170412
NCT06526117
NCT06665997
Lead Sponsor
Lifespan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions